National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/12/2021 release of VAERS data:

This is VAERS ID 1415930

Government Disclaimer on use of this data



Case Details

VAERS ID: 1415930 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-06-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous, Haemorrhage, SARS-CoV-2 test
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Termination of pregnancy and risk of abortion (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Folic acid supplementation; Lactation decreased; Pregnancy (Patient no longer pregnant at the time of reporting.)
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Test Result: Negative ; Comments: No - Negative
CDC Split Type: GBPFIZER INC2021657565

Write-up: bleeding; Miscarriage; This is a spontaneous report from a contactable consumer received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106051808003500-BUOMA. Safety Report Unique Identifier is GB-MHRA-ADR 25426261. A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on an unspecified date (Lot number was not reported) at single dose for COVID-19 immunization. Medical history included lactation decreased, pregnancy (Patient no longer pregnant at the time of reporting), folic acid supplementation. Patient did not have symptoms associated with COVID-19, patient is not enrolled in clinical trial, patient is not currently breastfeeding. Concomitant medication included folic acid taken for vitamin supplementation, start and stop date were not reported. The patient experienced bleeding, maternal exposure during pregnancy and miscarriage on an unspecified date. The events were serious for hospitalization. Patient had not been tested positive for COVID-19 since having the vaccine. There was an adverse effect on any aspect of the pregnancy for the medicine and pregnancy adverse effect was miscarriage. Patient was exposed to the medicine first-trimester (1-12 weeks). The patient started bleeding and miscarried 2 weeks later. The patient lab test included COVID-19 virus test: no-negative on an unspecified date. The outcome of bleeding was resolving, the outcome of other miscarriage was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1415930


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166